• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早发性患者携带 P77S 显性突变的最佳型卵黄样黄斑营养不良 (BVMD) 的 iPSC-RPE 模型中最佳质通道活性受损。

Impaired Bestrophin Channel Activity in an iPSC-RPE Model of Best Vitelliform Macular Dystrophy (BVMD) from an Early Onset Patient Carrying the P77S Dominant Mutation.

机构信息

Fundació de Recerca de l'Institut de Microcirurgia Ocular, 08035 Barcelona, Spain.

Departament de Genètica, Institut de Microcirurgia Ocular (IMO), Grupo Miranza, 08035 Barcelona, Spain.

出版信息

Int J Mol Sci. 2022 Jul 4;23(13):7432. doi: 10.3390/ijms23137432.

DOI:10.3390/ijms23137432
PMID:35806438
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9266689/
Abstract

Best Vitelliform Macular dystrophy (BVMD) is the most prevalent of the distinctive retinal dystrophies caused by mutations in the gene. This gene, which encodes for a homopentameric calcium-activated ion channel, is crucial for the homeostasis and function of the retinal pigment epithelia (RPE), the cell type responsible for recycling the visual pigments generated by photoreceptor cells. In BVMD patients, mutations in this gene induce functional problems in the RPE cell layer with an accumulation of lipofucsin that evolves into cell death and loss of sight. In this work, we employ iPSC-RPE cells derived from a patient with the p.Pro77Ser dominant mutation to determine the correlation between this variant and the ocular phenotype. To this purpose, gene and protein expression and localization are evaluated in iPSC-RPE cells along with functional assays like phagocytosis and anion channel activity. Our cell model shows no differences in gene expression, protein expression/localization, or phagocytosis capacity, but presents an increased chloride entrance, indicating that the p.Pro77Ser variant might be a gain-of-function mutation. We hypothesize that this variant disturbs the neck region of the BEST1 channel, affecting channel function but maintaining cell homeostasis in the short term. This data shed new light on the different phenotypes of dominant mutations in , and emphasize the importance of understanding its molecular mechanisms. Furthermore, the data widen the knowledge of this pathology and open the door for a better diagnosis and prognosis of the disease.

摘要

Best 型先天性类脂性视网膜炎(Best Vitelliform Macular dystrophy,BVMD)是由 基因突变引起的独特视网膜营养不良中最常见的一种。该基因编码五聚体钙激活离子通道,对视网膜色素上皮(retinal pigment epithelia,RPE)的稳态和功能至关重要,而 RPE 细胞是负责回收光感受器细胞产生的视觉色素的细胞类型。在 BVMD 患者中,该基因的突变会导致 RPE 细胞层出现功能问题,脂褐素积累,进而导致细胞死亡和视力丧失。在这项工作中,我们使用源自具有 p.Pro77Ser 显性突变的患者的诱导多能干细胞衍生的 RPE 细胞,以确定该变体与眼部表型之间的相关性。为此,我们评估了 iPSC-RPE 细胞中的基因和蛋白表达及定位,以及吞噬作用和阴离子通道活性等功能测定。我们的细胞模型在基因表达、蛋白表达/定位或吞噬能力方面没有差异,但表现出氯离子内流增加,表明 p.Pro77Ser 变体可能是一种功能获得性突变。我们假设该变体扰乱了 BEST1 通道的颈部区域,影响通道功能,但在短期内维持细胞稳态。这些数据为 中的显性突变的不同表型提供了新的见解,并强调了理解其分子机制的重要性。此外,这些数据拓宽了对该病理学的认识,并为疾病的更好诊断和预后开辟了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfe/9266689/aafd24b7c7bc/ijms-23-07432-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfe/9266689/5271f9431ede/ijms-23-07432-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfe/9266689/41755eb00da3/ijms-23-07432-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfe/9266689/287c9ce498d2/ijms-23-07432-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfe/9266689/9264c70ab26b/ijms-23-07432-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfe/9266689/2e04fbf46c61/ijms-23-07432-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfe/9266689/2883d331cb26/ijms-23-07432-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfe/9266689/aafd24b7c7bc/ijms-23-07432-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfe/9266689/5271f9431ede/ijms-23-07432-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfe/9266689/41755eb00da3/ijms-23-07432-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfe/9266689/287c9ce498d2/ijms-23-07432-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfe/9266689/9264c70ab26b/ijms-23-07432-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfe/9266689/2e04fbf46c61/ijms-23-07432-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfe/9266689/2883d331cb26/ijms-23-07432-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfe/9266689/aafd24b7c7bc/ijms-23-07432-g007.jpg

相似文献

1
Impaired Bestrophin Channel Activity in an iPSC-RPE Model of Best Vitelliform Macular Dystrophy (BVMD) from an Early Onset Patient Carrying the P77S Dominant Mutation.早发性患者携带 P77S 显性突变的最佳型卵黄样黄斑营养不良 (BVMD) 的 iPSC-RPE 模型中最佳质通道活性受损。
Int J Mol Sci. 2022 Jul 4;23(13):7432. doi: 10.3390/ijms23137432.
2
Bestrophin-1 influences transepithelial electrical properties and Ca2+ signaling in human retinal pigment epithelium.最佳rophin-1影响人视网膜色素上皮细胞的跨上皮电特性和Ca2+信号传导。
Mol Vis. 2015 Apr 1;21:347-59. eCollection 2015.
3
Differential effects of Best disease causing missense mutations on bestrophin-1 trafficking.Best 病致病错义突变对 bestrophin-1 转运的差异影响。
Hum Mol Genet. 2013 Dec 1;22(23):4688-97. doi: 10.1093/hmg/ddt316. Epub 2013 Jul 3.
4
BESTROPHIN1 mutations cause defective chloride conductance in patient stem cell-derived RPE.贝斯特罗芬1基因突变导致患者干细胞来源的视网膜色素上皮细胞中氯离子传导缺陷。
Hum Mol Genet. 2016 Jul 1;25(13):2672-2680. doi: 10.1093/hmg/ddw126. Epub 2016 May 18.
5
Small Molecules Restore Bestrophin 1 Expression and Function of Both Dominant and Recessive Bestrophinopathies in Patient-Derived Retinal Pigment Epithelium.小分子恢复了患者来源的视网膜色素上皮中显性和隐性 Bestrophinopathy 的 Bestrophin 1 表达和功能。
Invest Ophthalmol Vis Sci. 2020 May 11;61(5):28. doi: 10.1167/iovs.61.5.28.
6
Induced Pluripotent Stem Cell Modeling of Best Disease and Autosomal Recessive Bestrophinopathy.诱导多能干细胞模型构建中的 Best 病和常染色体隐性遗传性 Bestrophinopathy
Yonsei Med J. 2020 Sep;61(9):816-825. doi: 10.3349/ymj.2020.61.9.816.
7
Three-dimensional distribution of the vitelliform lesion, photoreceptors, and retinal pigment epithelium in the macula of patients with best vitelliform macular dystrophy.最佳卵黄样黄斑营养不良患者黄斑区卵黄样病变、光感受器及视网膜色素上皮的三维分布
Arch Ophthalmol. 2012 Mar;130(3):357-64. doi: 10.1001/archophthalmol.2011.363. Epub 2011 Nov 14.
8
Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies.突变依赖性病理机制决定了 Bestrophinopathy 的表型。
Int J Mol Sci. 2020 Feb 26;21(5):1597. doi: 10.3390/ijms21051597.
9
Disease-causing mutations associated with bestrophinopathies promote apoptosis in retinal pigment epithelium cells.与 Bestrophinopathies 相关的致病突变可促进视网膜色素上皮细胞凋亡。
Graefes Arch Clin Exp Ophthalmol. 2020 Oct;258(10):2251-2261. doi: 10.1007/s00417-020-04636-5. Epub 2020 Jun 7.
10
Disease-causing mutations associated with four bestrophinopathies exhibit disparate effects on the localization, but not the oligomerization, of Bestrophin-1.与四种 Bestrophin 病相关的致病突变对 Bestrophin-1 的定位有不同的影响,但对其寡聚化没有影响。
Exp Eye Res. 2014 Apr;121:74-85. doi: 10.1016/j.exer.2014.02.006. Epub 2014 Feb 19.

引用本文的文献

1
Clinical and Genetic Features of Autosomal Recessive Bestrophinopathy: A Case Series from a Vietnamese Cohort.常染色体隐性遗传性Bestrophinopathy的临床和遗传特征:来自越南队列的病例系列
Biomedicines. 2025 Jul 2;13(7):1625. doi: 10.3390/biomedicines13071625.
2
Rescue of the disease-associated phenotype in CRISPR-corrected hiPSCs as a therapeutic approach for inherited retinal dystrophies.在经CRISPR校正的人诱导多能干细胞中挽救疾病相关表型作为遗传性视网膜营养不良的一种治疗方法。
Mol Ther Nucleic Acids. 2025 Feb 11;36(1):102482. doi: 10.1016/j.omtn.2025.102482. eCollection 2025 Mar 11.
3
Endoplasmic reticulum stress and rhodopsin accumulation in an organoid model of Retinitis Pigmentosa carrying a RHO pathogenic variant.

本文引用的文献

1
The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease.遗传性视网膜疾病的新一代分子和细胞治疗方法。
Int J Mol Sci. 2021 Oct 26;22(21):11542. doi: 10.3390/ijms222111542.
2
Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics.基于细胞的视网膜疾病疗法:临床试验和直接面向消费者的“细胞疗法”诊所综述。
Stem Cell Res Ther. 2021 Oct 11;12(1):538. doi: 10.1186/s13287-021-02546-9.
3
Inducible Pluripotent Stem Cells to Model and Treat Inherited Degenerative Diseases of the Outer Retina: 3D-Organoids Limitations and Bioengineering Solutions.
携带RHO致病变体的色素性视网膜炎类器官模型中的内质网应激和视紫红质积累
Stem Cell Res Ther. 2025 Feb 14;16(1):71. doi: 10.1186/s13287-025-04199-4.
4
Ion channels research in hPSC-RPE cells: bridging benchwork to clinical applications.人胚胎干细胞视网膜色素上皮细胞的离子通道研究:从基础研究到临床应用的桥梁。
J Transl Med. 2024 Nov 27;22(1):1073. doi: 10.1186/s12967-024-05769-5.
5
Application of patient-derived induced pluripotent stem cells and organoids in inherited retinal diseases.诱导多能干细胞和类器官在遗传性视网膜疾病中的应用。
Stem Cell Res Ther. 2023 Nov 27;14(1):340. doi: 10.1186/s13287-023-03564-5.
诱导多能干细胞模型与治疗外视网膜遗传性退行性疾病:3D 类器官的局限性与生物工程解决方案。
Cells. 2021 Sep 20;10(9):2489. doi: 10.3390/cells10092489.
4
Disease expression caused by different variants in the BEST1 gene: genotype and phenotype findings in bestrophinopathies.由 BEST1 基因中的不同变异引起的疾病表型:贝斯特罗芬尼亚症的基因型和表型研究结果。
Acta Ophthalmol. 2022 May;100(3):e847-e858. doi: 10.1111/aos.14958. Epub 2021 Jul 29.
5
Characterization of PARP6 Function in Knockout Mice and Patients with Developmental Delay.PARP6 功能在敲除小鼠和发育迟缓患者中的特征分析。
Cells. 2021 May 22;10(6):1289. doi: 10.3390/cells10061289.
6
Distinct expression requirements and rescue strategies for loss- and gain-of-function mutations.具有不同表达要求的功能丧失和获得性突变的挽救策略。
Elife. 2021 Jun 1;10:e67622. doi: 10.7554/eLife.67622.
7
Bestrophinopathies: perspectives on clinical disease, Bestrophin-1 function and developing therapies.贝斯特病:临床疾病、贝斯特素-1功能及治疗进展的观点
Ther Adv Ophthalmol. 2021 Feb 27;13:2515841421997191. doi: 10.1177/2515841421997191. eCollection 2021 Jan-Dec.
8
Clinical Heterogeneity in Autosomal Recessive Bestrophinopathy with Biallelic Mutations in the Gene.常染色体隐性遗传性 Bestrophinopathy 伴双等位基因突变的临床异质性。
Int J Mol Sci. 2020 Dec 8;21(24):9353. doi: 10.3390/ijms21249353.
9
The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina.去泛素化酶 Ataxin-3 调控视网膜中的纤毛发生和吞噬作用。
Cell Rep. 2020 Nov 10;33(6):108360. doi: 10.1016/j.celrep.2020.108360.
10
Cellular Changes in Retinas From Patients With Mutations.患有突变的患者视网膜中的细胞变化。
Front Cell Dev Biol. 2020 Oct 14;8:573330. doi: 10.3389/fcell.2020.573330. eCollection 2020.